Literature DB >> 17222571

Chromosome transfer activates and delineates a locus control region for perforin.

Matthew E Pipkin1, Belma Ljutic, Fernando Cruz-Guilloty, Marcela Nouzova, Anjana Rao, Juan Carlos Zúñiga-Pflücker, Mathias G Lichtenheld.   

Abstract

Perforin gene (PRF1) transcription regulates perforin expression in NK cells and CTL. Here we identified the locus-wide ensemble of cis-acting sequences that drives PRF1 transcription physiologically. By using chromosome transfer, we revealed that de novo activation of a silent PRF1 locus was controlled by a 150 kb domain comprised of 16 DNase I hypersensitive sites (DHSs). These cis-acting sequences included a locus control region (LCR) and conferred developmentally appropriate and lineage-specific expression of human perforin from BAC transgenes. The LCR included four distal DHSs that were required for perforin expression from its natural locus, and their engineered deletion from the PRF1 BAC transgene abolished LCR function and led to rapid gene silencing. Thus, LCR function is central for regulating the developmental and activation-specific PRF1 promoter activity characteristic of NK cells and CTL.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17222571     DOI: 10.1016/j.immuni.2006.11.009

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  21 in total

Review 1.  The transcriptional control of the perforin locus.

Authors:  Matthew E Pipkin; Anjana Rao; Mathias G Lichtenheld
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

Review 2.  Genomics and the immune system.

Authors:  Matthew E Pipkin; Silvia Monticelli
Journal:  Immunology       Date:  2008-02-20       Impact factor: 7.397

3.  Defining the functional boundaries of the murine α1,3-fucosyltransferase Fut7 reveals a remarkably compact locus.

Authors:  Mark E Ebel; Geoffrey S Kansas
Journal:  J Biol Chem       Date:  2014-01-23       Impact factor: 5.157

Review 4.  Perforin and granzymes: function, dysfunction and human pathology.

Authors:  Ilia Voskoboinik; James C Whisstock; Joseph A Trapani
Journal:  Nat Rev Immunol       Date:  2015-06       Impact factor: 53.106

5.  Derivation of T cells in vitro from mouse embryonic stem cells.

Authors:  Martina Kučerová-Levisohn; Jordana Lovett; Armin Lahiji; Roxanne Holmes; Juan Carlos Zúñiga-Pflücker; Benjamin D Ortiz
Journal:  J Vis Exp       Date:  2014-10-14       Impact factor: 1.355

6.  Knocking 'em Dead: Pore-Forming Proteins in Immune Defense.

Authors:  Xing Liu; Judy Lieberman
Journal:  Annu Rev Immunol       Date:  2020-01-31       Impact factor: 28.527

7.  Antigen-specific clonal expansion and cytolytic effector function of CD8+ T lymphocytes depend on the transcription factor Bcl11b.

Authors:  Shuning Zhang; Mike Rozell; Raj K Verma; Diana I Albu; Danielle Califano; Jeffrey VanValkenburgh; Akeel Merchant; Javier Rangel-Moreno; Troy D Randall; Nancy A Jenkins; Neal G Copeland; Pentao Liu; Dorina Avram
Journal:  J Exp Med       Date:  2010-07-26       Impact factor: 14.307

8.  The host defense peptide cathelicidin is required for NK cell-mediated suppression of tumor growth.

Authors:  Amanda S Büchau; Shin Morizane; Janet Trowbridge; Jürgen Schauber; Paul Kotol; Jack D Bui; Richard L Gallo
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

9.  Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells.

Authors:  Matthew E Pipkin; Jilian A Sacks; Fernando Cruz-Guilloty; Mathias G Lichtenheld; Michael J Bevan; Anjana Rao
Journal:  Immunity       Date:  2010-01-21       Impact factor: 31.745

10.  Noninvasive imaging of cell-mediated therapy for treatment of cancer.

Authors:  Elizabeth J Akins; Purnima Dubey
Journal:  J Nucl Med       Date:  2008-06       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.